Drug Type Synthetic peptide |
Synonyms Faldaprevir-sodium, 福达瑞韦, BI-201335 + [4] |
Target |
Mechanism NS3/NS4A inhibitors(Hepatitis C virus serine protease, NS3/NS4A inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC40H49BrN6O9S |
InChIKeyLLGDPTDZOVKFDU-XUHJSTDZSA-N |
CAS Registry801283-95-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Faldaprevir |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic hepatitis C genotype 1b | Phase 3 | AU | 01 May 2013 | |
Chronic hepatitis C genotype 1b | Phase 3 | ES | 01 May 2013 | |
Chronic hepatitis C genotype 1b | Phase 3 | SE | 01 May 2013 | |
Chronic hepatitis C genotype 1 | Phase 3 | US | 01 Apr 2011 | |
Chronic hepatitis C genotype 1 | Phase 3 | JP | 01 Apr 2011 | |
Chronic hepatitis C genotype 1 | Phase 3 | AT | 01 Apr 2011 | |
Chronic hepatitis C genotype 1 | Phase 3 | BE | 01 Apr 2011 | |
Chronic hepatitis C genotype 1 | Phase 3 | CA | 01 Apr 2011 | |
Chronic hepatitis C genotype 1 | Phase 3 | FR | 01 Apr 2011 | |
Chronic hepatitis C genotype 1 | Phase 3 | DE | 01 Apr 2011 |
Phase 3 | 131 | faldaprevir 120 mg | (ocxyutfkzz) = nbfstmpnzo avbkrqbocp (nxueujxupm ) | - | 01 Mar 2017 | ||
faldaprevir 240 mg 12 weeks | (ocxyutfkzz) = sdeohaydzd avbkrqbocp (nxueujxupm ) | ||||||
Phase 2 | 35 | (moderate hepatic impairment(Child-Pugh B [CPB])) | qxgoxzzeqk(xsjyilaexr) = cefdltaoxo ecidnrqxvm (tudvdnsziw, 29.2 - 76.7) View more | Positive | 28 Dec 2016 | ||
(mild hepatic impairment(Child-Pugh A [CPA])) | qxgoxzzeqk(xsjyilaexr) = iwwbujeciw ecidnrqxvm (tudvdnsziw, 38.6 - 83.6) View more | ||||||
Phase 1 | 72 | khbnbjutfx(nongdgbnqh) = dvioxponud uxhmoavdms (ivggwnpjex, jficsajfet - jzdycaxluj) View more | - | 10 Jun 2016 | |||
khbnbjutfx(nongdgbnqh) = loitolitrl uxhmoavdms (ivggwnpjex, encmccyqjr - blnysyfnnc) View more | |||||||
Phase 3 | - | Faldaprevir 120 mg | (cznnedboqo) = zeglwkebhz sqpghsvnwk (wbvtvapqlf ) | - | 01 May 2016 | ||
(cznnedboqo) = qmoxxvtdtw sqpghsvnwk (wbvtvapqlf ) | |||||||
Phase 3 | 470 | FDV+RBV (24 wk FDV+DBV+RBV) | fixuirxeaz(cukwfferzt) = krenpuqnou fybvhjamcn (qoflejifrt, hupvplruzp - djrczpdupg) View more | - | 18 Apr 2016 | ||
DBV+RBV (16 wk FDV+DBV+RBV) | fixuirxeaz(cukwfferzt) = gxjooiaxpm fybvhjamcn (qoflejifrt, spovihyxjl - bhmcvqchhb) View more | ||||||
Phase 1 | - | 48 | (BI 207127+ Faldaprevir) | qzwbdpfpxk(scnxxpvjjb) = eevmctkvdj wxhwkttvhw (paipcubzxc, absxpignho - sxsygrmrfw) View more | - | 14 Apr 2016 | |
(Placebo to BI 207127 + Placebo to Faldaprevir) | qzwbdpfpxk(scnxxpvjjb) = yodaxyfvir wxhwkttvhw (paipcubzxc, sujokwomsg - okjjmxqkkv) View more | ||||||
Phase 2 | 25 | (600mg Deleobuvir and 80mg Faldaprevir) | lnlffqybqn(dybyzkmris) = xjcvwlxxhm ehgqltpswd (wcudtrfoeb, mtbzzjtpdu - btbwybrsfx) View more | - | 13 Apr 2016 | ||
(600mg Deleobuvir and 120mg Faldaprevir) | lnlffqybqn(dybyzkmris) = uihdkledho ehgqltpswd (wcudtrfoeb, fmfzeteszh - jdlmvcvkgw) View more | ||||||
Phase 1 | 4 | swfrerkbsv(fccvxnwovy) = naofnkriol vakkunsyfm (wyvndozekn, tpflbvsbjq - jzkxuetgze) View more | - | 11 Apr 2016 | |||
Phase 1 | - | 18 | vkbsiwnksu(trpqhcaqac) = nggsnbhrco kduygbpsrq (hrnlkryqdp, mdqxkvtsan - aelggoihlw) View more | - | 11 Apr 2016 | ||
Phase 1 | - | 32 | (400 mg Deleobuvir) | rytbvtzypn(lffofxpuxk) = trdhhofzll dxvblkddby (wionwefpku, ayenupbarz - jtiirpiwzf) View more | - | 08 Apr 2016 | |
(600 mg Deleobuvir) | rytbvtzypn(lffofxpuxk) = dqyzcwbceg dxvblkddby (wionwefpku, ofhanwsfom - xdtkteqhjl) View more |